Change search
ReferencesLink to record
Permanent link

Direct link
Survival analysis of patients with a PFS event who did not receive post-progression therapy in AVAglio (bevacizumab [BEV] plus radiotherapy [RT] and temozolomide [TMZ] for newly diagnosed glioblastoma [GBM])
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology. Regional Cancer Center, Karolinska University Hospital, Stockholm, Sweden.
Show others and affiliations
2014 (English)In: Neuro-Oncology, ISSN 1522-8517, E-ISSN 1523-5866, Vol. 16, no 5Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2014. Vol. 16, no 5
National Category
Cancer and Oncology
URN: urn:nbn:se:umu:diva-101425DOI: 10.1093/neuonc/nou237.18ISI: 000350452200048OAI: diva2:800250
19th Annual Scientific Meeting of the Society for Neuro-Oncology, Miami, Florida, November 13-16, 2014
Available from: 2015-04-02 Created: 2015-03-30 Last updated: 2015-04-02Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Henriksson, Roger
By organisation
In the same journal
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 55 hits
ReferencesLink to record
Permanent link

Direct link